ExPRES SEPSIS
Start date:January 2014 End date:
July 2015 Co-ordinated by:
University of Edinburgh & NHS Lothian
Early Prediction of Severe Sepsis
Aim
To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis
Trial Design
A Prospective, multi-centre cohort observational study
Chief Investigator
Professor Tim Walsh, Critical Care Research Group
Local PI
Professor Tim Walsh
Research Team
- EMERGE Research team
- Critical Care Research Group
- Rossi Lab, MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh
Eligibility criteria (summary)
Patients who present to the Emergency Department with suspected sepsis
Further information
http://www.ccm.mvm.ed.ac.uk/
http://www.cir.ed.ac.uk/
Research Team
Dr Deepankar Datta
Specialist Trainee Emergency Medicine
Julia Grahamslaw
Lead Research Nurse
Related news
More EMERGE Trials
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)
Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.
NOVEL Study
Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions